When MAT2A is blocked in MTAP-deleted cancer cells, PRMT5 is more affected than other enzymes that use SAM, indicating that PRMT5 is more vulnerable to low SAM levels than other cellular processes.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Whether PRMT5 inhibition consistently occurs at lower SAM levels than other methyltransferases across clinical samples treated with MAT2A inhibitors.
A systematic review and meta-analysis of all published studies measuring SAM levels and methylation of 10+ SAM-dependent enzymes (e.g., DNMTs, G9a, SETD7) in tumor biopsies from patients treated with MAT2A inhibitors, correlating SAM concentration thresholds with enzyme inhibition.
Whether titrating SAM levels in vivo selectively inhibits PRMT5 over other methyltransferases.
A phase I RCT in 60 patients with MTAP-deleted tumors, administering escalating doses of IDE397 with serial biopsies to measure SAM levels and methylation of PRMT5, DNMT1, G9a, and SETD7, identifying the SAM threshold at which each enzyme is inhibited.
Whether tumors with lower baseline SAM show greater PRMT5 suppression relative to other methyltransferases.
A prospective cohort of 120 MTAP-deleted tumor patients treated with IDE397, measuring pre- and post-treatment SAM levels and methylation of 8 SAM-dependent enzymes in paired biopsies, calculating relative inhibition ratios.
Whether non-responders to IDE397 have altered SAM utilization hierarchies.
A matched case-control study comparing 30 responders and 30 non-responders to IDE397, analyzing relative inhibition of PRMT5 vs. DNMT1, G9a, and SETD7 in tumor tissue to determine if hierarchy is disrupted in resistance.
The relative sensitivity of PRMT5 versus other methyltransferases to SAM depletion in MTAP-deleted tumors.
A cross-sectional analysis of 200 MTAP-deleted tumor samples, measuring SAM concentration and methylation levels of 10 SAM-dependent enzymes to determine which enzymes are inhibited at the lowest SAM thresholds.